Topical Oxybutynin for Treatment of Hyperidrosis: a Local or a Systemic Effect? (TODAY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05102396

Recruitment Status : Unknown

Verified October 2021 by Samantha Rodrigues Camargo Neves de Moura, Science Valley Research Institute.
Recruitment status was: Not yet recruiting

First Posted : November 1, 2021

Last Update Posted : November 1, 2021

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Science Valley Research Institute

Information provided by (Responsible Party):

Samantha Rodrigues Camargo Neves de Moura, Science Valley Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 2022
Estimated Study Completion Date :	June 2022

Publications:

de Campos JR, Kauffman P, Werebe Ede C, Andrade Filho LO, Kusniek S, Wolosker N, Jatene FB. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003 Sep;76(3):886-91. doi: 10.1016/s0003-4975(03)00895-6.

Sharma P, Patel DP, Sanyal M, Berawala H, Guttikar S, Shrivastav PS. Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study. J Pharm Biomed Anal. 2013 Oct;84:244-55. doi: 10.1016/j.jpba.2013.06.024. Epub 2013 Jun 28.

To Top